The Auris transaction was proceeded by a number of ventures by Chris that set gold standard for motion preservation, regeneration of cartilage and soft tissue through the use of novel peptides and regenerative medicine.

A recent example is Auris Health which was recognized by CNBC as one of the 50 most disruptive companies in the world. Investments, returns and valuations from seven companies founded, developed and/or brought to exit by Chris have benefited from more than $5.77 billion in returns realized to all investors through exits. Chris not only offers investments guidance and critical research and industry connections, but also helps guide each portfolio company along the fund's proven, proprietary process that reduces new venture risk and enhances returns.Ĭompanies developed by Chris have created considerable value. As Founder and Executive Chairman of Miraki Innovation, Chris forecasts imminent global health and medical challenges, uncovers technologies at leading research institutions and assembles teams of industry experts to solve these global problems. Scott and his team at LSI have conducted numerous market research projects for top medical device manufacturers including Johnson & Johnson, Medtronic, Boston Scientific, Abbott, Becton Dickinson, Teleflex, Cardinal Health, GE Healthcare, and Stryker, among others.Ĭhris is a prolific entrepreneur and venture capitalist who has pioneered some of the most innovative medical technologies brought to market in the last decades. He has held leadership roles as a strategic partner for Elsevier Business Intelligence, Health Research Intelligence, and Informa Business Intelligence. Prior to founding LSI, he held senior executive roles with renowned life science data providers including Medical Data International, Medtech Insight and Windhover Information. He has been in the medtech market intelligence business for over 20 years supporting venture funded startups, major strategics, and life science investors as they navigate the ever-changing medtech marketplace.

Scott is the President, CEO and Founder of Life Science Intelligence. Scott's mission at the meeting will be to connect the investors, innovators and strategics that are driving the future of medtech. Scott will join his team of exclusive sponsors to host the Emerging Medtech Summit.

History Quest by Lisa Hawkins